These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 28425751)

  • 1. Development of red blood cell autoantibodies following treatment with checkpoint inhibitors: a new class of anti-neoplastic, immunotherapeutic agents associated with immune dysregulation.
    Cooling LL; Sherbeck J; Mowers JC; Hugan SL
    Immunohematology; 2017 Jan; 33(1):15-21. PubMed ID: 28425751
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nivolumab-induced autoimmune diabetes mellitus presenting as diabetic ketoacidosis in a patient with metastatic lung cancer.
    Godwin JL; Jaggi S; Sirisena I; Sharda P; Rao AD; Mehra R; Veloski C
    J Immunother Cancer; 2017; 5():40. PubMed ID: 28515940
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacovigilance Assessment of Immune-Mediated Reactions Reported for Checkpoint Inhibitor Cancer Immunotherapies.
    Ali AK; Watson DE
    Pharmacotherapy; 2017 Nov; 37(11):1383-1390. PubMed ID: 28950039
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The safety of therapeutic monoclonal antibodies: implications for cancer therapy including immuno-checkpoint inhibitors.
    Demlova R; Valík D; Obermannova R; ZdraŽilová-Dubská L
    Physiol Res; 2016 Dec; 65(Suppl 4):S455-S462. PubMed ID: 28006927
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of toxicities of immune checkpoint inhibitors.
    Spain L; Diem S; Larkin J
    Cancer Treat Rev; 2016 Mar; 44():51-60. PubMed ID: 26874776
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Management of Toxicities of Immune Checkpoint Inhibitors].
    Horio Y
    Gan To Kagaku Ryoho; 2017 Mar; 44(3):185-190. PubMed ID: 28292987
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of immune-related systemic adverse events in patients treated with anti-Programmed cell Death 1/anti-Programmed cell Death-Ligand 1 agents: A single-centre pharmacovigilance database analysis.
    Le Burel S; Champiat S; Mateus C; Marabelle A; Michot JM; Robert C; Belkhir R; Soria JC; Laghouati S; Voisin AL; Fain O; Mékinian A; Coutte L; Szwebel TA; Dunogeant L; Lioger B; Luxembourger C; Mariette X; Lambotte O
    Eur J Cancer; 2017 Sep; 82():34-44. PubMed ID: 28646772
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Positive direct antiglobulin tests in cancer patients on immune checkpoint inhibitors: A case series from India.
    Datta SS; De D
    Transfus Clin Biol; 2023 Aug; 30(3):341-344. PubMed ID: 36931491
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of arthralgias in adult oncology patients receiving immune checkpoint inhibitors.
    Lee J; Graham A; Sion A
    J Oncol Pharm Pract; 2019 Dec; 25(8):1867-1872. PubMed ID: 30651028
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IgG red blood cell autoantibodies in autoimmune hemolytic anemia bind to epitopes on red blood cell membrane band 3 glycoprotein.
    Victoria EJ; Pierce SW; Branks MJ; Masouredis SP
    J Lab Clin Med; 1990 Jan; 115(1):74-88. PubMed ID: 1688911
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myasthenia gravis: An emerging toxicity of immune checkpoint inhibitors.
    Makarious D; Horwood K; Coward JIG
    Eur J Cancer; 2017 Sep; 82():128-136. PubMed ID: 28666240
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety of pembrolizumab for the treatment of melanoma.
    Martin-Liberal J; Kordbacheh T; Larkin J
    Expert Opin Drug Saf; 2015 Jun; 14(6):957-64. PubMed ID: 25927979
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Supportive care for patients undergoing immunotherapy.
    Rapoport BL; van Eeden R; Sibaud V; Epstein JB; Klastersky J; Aapro M; Moodley D
    Support Care Cancer; 2017 Oct; 25(10):3017-3030. PubMed ID: 28707167
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A case of pure red cell aplasia during nivolumab therapy for cardiac metastatic melanoma.
    Yuki A; Takenouchi T; Takatsuka S; Ishiguro T
    Melanoma Res; 2017 Dec; 27(6):635-637. PubMed ID: 28872489
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autoimmune Endocrine Dysfunctions Associated with Cancer Immunotherapies.
    Ferrari SM; Fallahi P; Elia G; Ragusa F; Ruffilli I; Patrizio A; Galdiero MR; Baldini E; Ulisse S; Marone G; Antonelli A
    Int J Mol Sci; 2019 May; 20(10):. PubMed ID: 31137683
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serologic findings in autoimmune hemolytic anemia associated with immunoglobulin M warm autoantibodies.
    Arndt PA; Leger RM; Garratty G
    Transfusion; 2009 Feb; 49(2):235-42. PubMed ID: 18980619
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Severe neurologic complications of immune checkpoint inhibitors: a single-center review.
    Mancone S; Lycan T; Ahmed T; Topaloglu U; Dothard A; Petty WJ; Strowd RE
    J Neurol; 2018 Jul; 265(7):1636-1642. PubMed ID: 29761297
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endocrine side effects induced by immune checkpoint inhibitors.
    Corsello SM; Barnabei A; Marchetti P; De Vecchis L; Salvatori R; Torino F
    J Clin Endocrinol Metab; 2013 Apr; 98(4):1361-75. PubMed ID: 23471977
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinicopathological features of acute kidney injury associated with immune checkpoint inhibitors.
    Cortazar FB; Marrone KA; Troxell ML; Ralto KM; Hoenig MP; Brahmer JR; Le DT; Lipson EJ; Glezerman IG; Wolchok J; Cornell LD; Feldman P; Stokes MB; Zapata SA; Hodi FS; Ott PA; Yamashita M; Leaf DE
    Kidney Int; 2016 Sep; 90(3):638-47. PubMed ID: 27282937
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Silent red blood cell autoantibodies: Are they naturally occurring or an effect of tolerance loss for a subsequent autoimmune process?
    Torres-Aguilar H; Sosa-Luis SA; Ríos-Ríos WJ; Romero-Tlalolini MLÁ; Aguilar-Ruiz SR
    Autoimmunity; 2020 Nov; 53(7):367-375. PubMed ID: 32815426
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.